chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Bradycardia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient was an 81-year-old gentleman past medical history A. fib on Eliquis, hypertension, prostate cancer diagnosed in 2017 enrolled in clinical trial, admitted to the medical ICU at Hospital for acute hypoxic respiratory failure secondary to Covid pneumonia, transferred from Hedrick Medical Center for acute worsening of his hypoxia. Intubated on 12/2/21.  After multiple failed attempts, the patient passed his ZEEP on 12/15 and patient was extubated to NIPPV. s/p Dexamethasone 12/02-12/05, remdesivir 12/02-12/06, baricitinib 12/02-12/09 AND Tocilizumab 12/09 Hospital course complicated by bradycardia and concern for possible AV block vs junctional rhythm. Cardiology felt that the patient did not have a complete heart block.   Discussion had with patient on 12/16 with wife at bedside about respiratory status and if need for reintubation occurred what his choice would be.  Patient was wearing BiPAP and shaking his head to answer questions.  Was following commands appropriately.  Patient asked directly if his respiratory status would worsen and he was about to die would he want a tube down his throat again and placed on the ventilator, patient shook his head no multiple times.  Wife was present during this encounter and was in agreement to honor patient's wishes.  Patient's CODE STATUS is DNR/DNI.  since extubation  12/15 patient failed multiple attempts to wean O2 requirement to HFNC and required to be put back on BiPAP due to worsening resp status.s/p lasix with adequate urine output.  Chest x-ray noted worsening bilateral opacities consistent with COVID-19 on 12/18.   Family discussion 12/19: Goals of care discussion had at bedside with patient's wife, daughter, and daughter (via phone).  Discussed worsening respiratory status, increased work of breathing, and patient comfort.  Patient expressed his wishes the other day to be DNR/DNI; Family expressed understanding that patient is worsening and they would want to transition to comfort. All family questions were answered.   Family was able to gather at bedside on 12/20/2021 and patient was transitioned to comfort care and taken off respiratory support. The patient passed away at 17:45 with family at bedside. Pronounced by MD.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dyspnoea, Endotracheal intubation, General physical health deterioration, Hypoxia
Clinical narrative: Patient was an 81-year-old gentleman past medical history A. fib on Eliquis, hypertension, prostate cancer diagnosed in 2017 enrolled in clinical trial, admitted to the medical ICU at Hospital for acute hypoxic respiratory failure secondary to Covid pneumonia, transferred from Hedrick Medical Center for acute worsening of his hypoxia. Intubated on 12/2/21.  After multiple failed attempts, the patient passed his ZEEP on 12/15 and patient was extubated to NIPPV. s/p Dexamethasone 12/02-12/05, remdesivir 12/02-12/06, baricitinib 12/02-12/09 AND Tocilizumab 12/09 Hospital course complicated by bradycardia and concern for possible AV block vs junctional rhythm. Cardiology felt that the patient did not have a complete heart block.   Discussion had with patient on 12/16 with wife at bedside about respiratory status and if need for reintubation occurred what his choice would be.  Patient was wearing BiPAP and shaking his head to answer questions.  Was following commands appropriately.  Patient asked directly if his respiratory status would worsen and he was about to die would he want a tube down his throat again and placed on the ventilator, patient shook his head no multiple times.  Wife was present during this encounter and was in agreement to honor patient's wishes.  Patient's CODE STATUS is DNR/DNI.  since extubation  12/15 patient failed multiple attempts to wean O2 requirement to HFNC and required to be put back on BiPAP due to worsening resp status.s/p lasix with adequate urine output.  Chest x-ray noted worsening bilateral opacities consistent with COVID-19 on 12/18.   Family discussion 12/19: Goals of care discussion had at bedside with patient's wife, daughter, and daughter (via phone).  Discussed worsening respiratory status, increased work of breathing, and patient comfort.  Patient expressed his wishes the other day to be DNR/DNI; Family expressed understanding that patient is worsening and they would want to transition to comfort. All family questions were answered.   Family was able to gather at bedside on 12/20/2021 and patient was transitioned to comfort care and taken off respiratory support. The patient passed away at 17:45 with family at bedside. Pronounced by MD.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Lung opacity, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: Patient was an 81-year-old gentleman past medical history A. fib on Eliquis, hypertension, prostate cancer diagnosed in 2017 enrolled in clinical trial, admitted to the medical ICU at Hospital for acute hypoxic respiratory failure secondary to Covid pneumonia, transferred from Hedrick Medical Center for acute worsening of his hypoxia. Intubated on 12/2/21.  After multiple failed attempts, the patient passed his ZEEP on 12/15 and patient was extubated to NIPPV. s/p Dexamethasone 12/02-12/05, remdesivir 12/02-12/06, baricitinib 12/02-12/09 AND Tocilizumab 12/09 Hospital course complicated by bradycardia and concern for possible AV block vs junctional rhythm. Cardiology felt that the patient did not have a complete heart block.   Discussion had with patient on 12/16 with wife at bedside about respiratory status and if need for reintubation occurred what his choice would be.  Patient was wearing BiPAP and shaking his head to answer questions.  Was following commands appropriately.  Patient asked directly if his respiratory status would worsen and he was about to die would he want a tube down his throat again and placed on the ventilator, patient shook his head no multiple times.  Wife was present during this encounter and was in agreement to honor patient's wishes.  Patient's CODE STATUS is DNR/DNI.  since extubation  12/15 patient failed multiple attempts to wean O2 requirement to HFNC and required to be put back on BiPAP due to worsening resp status.s/p lasix with adequate urine output.  Chest x-ray noted worsening bilateral opacities consistent with COVID-19 on 12/18.   Family discussion 12/19: Goals of care discussion had at bedside with patient's wife, daughter, and daughter (via phone).  Discussed worsening respiratory status, increased work of breathing, and patient comfort.  Patient expressed his wishes the other day to be DNR/DNI; Family expressed understanding that patient is worsening and they would want to transition to comfort. All family questions were answered.   Family was able to gather at bedside on 12/20/2021 and patient was transitioned to comfort care and taken off respiratory support. The patient passed away at 17:45 with family at bedside. Pronounced by MD.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Hyperhidrosis, Pyrexia
Clinical narrative: chills, diaphoresis, fatigue, fever
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: chills, diaphoresis, fatigue, fever
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 1/25/21 and 2/16/21. On 1/22/22, patient admitted to our inpatient med/surg unit with acute hypoxic respiratory failure due to COVID19 infection. As of today (1/25/22), patient is still admitted in the med/surg unit wth hypoxia.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: I developed headaches after the vaccine. I never had headaches before in my life and every now and then I would get these sharp pains in different spots in my head. I could feel where the headache was. These would come and go. Sometimes I would get them daily for a few days and then they would disappear for a few weeks and then return.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: 32 hours of vomiting, fever, chills, body pain, headache and tired.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 32 hours of vomiting, fever, chills, body pain, headache and tired.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Lymph node pain, Lymphadenopathy, Nausea
Clinical narrative: Fever, chills, headache, nausea  (days 2-3), sore arm (days 1-4), swollen and painful axillary lymph nodes (left) still ongoing (stared day 3- now on day 5.)
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever, chills, headache, nausea  (days 2-3), sore arm (days 1-4), swollen and painful axillary lymph nodes (left) still ongoing (stared day 3- now on day 5.)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Nausea
Clinical narrative: fever, chills, generalized body aches, cough, and nausea, vomiting, and diarrhea
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: fever, chills, generalized body aches, cough, and nausea, vomiting, and diarrhea
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Covid positive through household member.  Not due booster at this time
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fever, shivers, achiness, fatigue the next day
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Headache, Stomach pain, fatigue, sore throat
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Order obtained for patient to receive Covid booster injection (Pfizer) for 21 year old patient.  RN presented to Med room and drew medication from Pfizer clipboard for 12years and older.  Documented Lot number and provided patient with IM injection.  Upon documentation of injection, lot numbers did not match.  With assistance of staff member, vials were noted to have been switched.  Medication patient received was Pfizer 5-11 yo.  Event reported to NM, provider and Director of Medicine.  Incident report filed and patient notified and was offered appt for repeat Booster.  Pt did not keep appointment
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic spontaneous urticaria, Mechanical urticaria
Clinical narrative: Chronic Spontaneous Uticaria, Demographia
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature increased, Chills, Myalgia, Pain
Clinical narrative: I had muscle aches, chills and a temperature of 100.2 at 0140am.  The aches and temperature lowered throughout the morning on 01/25/2022.  At approximately 1530 in the afternoon, temperature 102, aches, and chills, again.  I also feel weak.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Dyspnoea, Headache, Malaise
Clinical narrative: headache, scratchy throat, cough w/ occas short of breath and dizziness started on 12/24/21, the day after receiving the Moderna booster. Visit to walk-in clinic on 12/30/21 due to continued symptoms and feeling unwell. Dr. exam was positive for nasal mucosa edema and rhinorrhea. Prednisone ordered for 5 days for viral upper respiratory infection. Saline nasal rinses also suggested by provider and were performed once to twice a day. Today I still continue to have headaches and cough, but cough is decreasing.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Rhinorrhoea, Throat irritation, Upper respiratory tract infection
Clinical narrative: headache, scratchy throat, cough w/ occas short of breath and dizziness started on 12/24/21, the day after receiving the Moderna booster. Visit to walk-in clinic on 12/30/21 due to continued symptoms and feeling unwell. Dr. exam was positive for nasal mucosa edema and rhinorrhea. Prednisone ordered for 5 days for viral upper respiratory infection. Saline nasal rinses also suggested by provider and were performed once to twice a day. Today I still continue to have headaches and cough, but cough is decreasing.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: cough, short of breath, hypoxia
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acidosis, Acute respiratory failure, Atrial fibrillation, COVID-19, Clostridium difficile colitis
Clinical narrative: Hospital Course   69-year-old female with past medical history of atrial fibrillation cardiomyopathy (last EF's 71% on 12/2 & 50% 02/21), myasthenia gravis transferred from Hospital for vertebral osteomyelitis and MSSA bacteremia, atrial fib and altered mental status. Admitted on 11/4 and has since been receiving medical management of vertebral osteomyelitis/discitis/epidural abscess at L1-L3. Has had multiple medications and changes since admission with her current medication being cefazolin. Hospital course has been very complicated with patient first developing C. diff colitis and treated with oral vancomycin and subsequently continued on prophylaxis dosing. She also developing AHRF on 12/01 secondary to COVID requiring NIPPV. 12/02 patient's respiratory status continued to decline and patient was intubated with consent from her brother. Neurology was consulted due to her altered mental status and concern that her myasthenia was contributing. They were able to recommend downtitrating her mycophenalate and pyridostigamine and holding prednisone. Patient had refractory acidosis and started on SLED but was unable to tolerate it initially but has been able to tolerate CRRT and CVVHDF. Patient has also been complicated with concerns for HIT; however, studies are not suggestive and argatroban drip was discontinued. Also has been in atrial fibrillation. Lastly, patient's Hgb dopped and CT abdomen was down which showed pancreatitis and peripancreatic/retroperitoneal fluid collection with some blood products. GI consulted and feel that pancreatitis was likely due to COVID19. Due to the continued deterioration of the patient's condition despite maximal medical effort, patient's brother, with discussion with palliative medicine, decided to pursue comfort care. patient was placed on comfort care 12/14 and expired 17:21. Family was contacted, declines autopsy.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abdomen abnormal, Condition aggravated, Death, Endotracheal intubation, Extradural abscess
Clinical narrative: Hospital Course   69-year-old female with past medical history of atrial fibrillation cardiomyopathy (last EF's 71% on 12/2 & 50% 02/21), myasthenia gravis transferred from Hospital for vertebral osteomyelitis and MSSA bacteremia, atrial fib and altered mental status. Admitted on 11/4 and has since been receiving medical management of vertebral osteomyelitis/discitis/epidural abscess at L1-L3. Has had multiple medications and changes since admission with her current medication being cefazolin. Hospital course has been very complicated with patient first developing C. diff colitis and treated with oral vancomycin and subsequently continued on prophylaxis dosing. She also developing AHRF on 12/01 secondary to COVID requiring NIPPV. 12/02 patient's respiratory status continued to decline and patient was intubated with consent from her brother. Neurology was consulted due to her altered mental status and concern that her myasthenia was contributing. They were able to recommend downtitrating her mycophenalate and pyridostigamine and holding prednisone. Patient had refractory acidosis and started on SLED but was unable to tolerate it initially but has been able to tolerate CRRT and CVVHDF. Patient has also been complicated with concerns for HIT; however, studies are not suggestive and argatroban drip was discontinued. Also has been in atrial fibrillation. Lastly, patient's Hgb dopped and CT abdomen was down which showed pancreatitis and peripancreatic/retroperitoneal fluid collection with some blood products. GI consulted and feel that pancreatitis was likely due to COVID19. Due to the continued deterioration of the patient's condition despite maximal medical effort, patient's brother, with discussion with palliative medicine, decided to pursue comfort care. patient was placed on comfort care 12/14 and expired 17:21. Family was contacted, declines autopsy.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Haemoglobin decreased, Intervertebral discitis, Mental status changes, Osteomyelitis
Clinical narrative: Hospital Course   69-year-old female with past medical history of atrial fibrillation cardiomyopathy (last EF's 71% on 12/2 & 50% 02/21), myasthenia gravis transferred from Hospital for vertebral osteomyelitis and MSSA bacteremia, atrial fib and altered mental status. Admitted on 11/4 and has since been receiving medical management of vertebral osteomyelitis/discitis/epidural abscess at L1-L3. Has had multiple medications and changes since admission with her current medication being cefazolin. Hospital course has been very complicated with patient first developing C. diff colitis and treated with oral vancomycin and subsequently continued on prophylaxis dosing. She also developing AHRF on 12/01 secondary to COVID requiring NIPPV. 12/02 patient's respiratory status continued to decline and patient was intubated with consent from her brother. Neurology was consulted due to her altered mental status and concern that her myasthenia was contributing. They were able to recommend downtitrating her mycophenalate and pyridostigamine and holding prednisone. Patient had refractory acidosis and started on SLED but was unable to tolerate it initially but has been able to tolerate CRRT and CVVHDF. Patient has also been complicated with concerns for HIT; however, studies are not suggestive and argatroban drip was discontinued. Also has been in atrial fibrillation. Lastly, patient's Hgb dopped and CT abdomen was down which showed pancreatitis and peripancreatic/retroperitoneal fluid collection with some blood products. GI consulted and feel that pancreatitis was likely due to COVID19. Due to the continued deterioration of the patient's condition despite maximal medical effort, patient's brother, with discussion with palliative medicine, decided to pursue comfort care. patient was placed on comfort care 12/14 and expired 17:21. Family was contacted, declines autopsy.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pancreatitis, Peripancreatic fluid collection, SARS-CoV-2 test positive, Staphylococcal bacteraemia
Clinical narrative: Hospital Course   69-year-old female with past medical history of atrial fibrillation cardiomyopathy (last EF's 71% on 12/2 & 50% 02/21), myasthenia gravis transferred from Hospital for vertebral osteomyelitis and MSSA bacteremia, atrial fib and altered mental status. Admitted on 11/4 and has since been receiving medical management of vertebral osteomyelitis/discitis/epidural abscess at L1-L3. Has had multiple medications and changes since admission with her current medication being cefazolin. Hospital course has been very complicated with patient first developing C. diff colitis and treated with oral vancomycin and subsequently continued on prophylaxis dosing. She also developing AHRF on 12/01 secondary to COVID requiring NIPPV. 12/02 patient's respiratory status continued to decline and patient was intubated with consent from her brother. Neurology was consulted due to her altered mental status and concern that her myasthenia was contributing. They were able to recommend downtitrating her mycophenalate and pyridostigamine and holding prednisone. Patient had refractory acidosis and started on SLED but was unable to tolerate it initially but has been able to tolerate CRRT and CVVHDF. Patient has also been complicated with concerns for HIT; however, studies are not suggestive and argatroban drip was discontinued. Also has been in atrial fibrillation. Lastly, patient's Hgb dopped and CT abdomen was down which showed pancreatitis and peripancreatic/retroperitoneal fluid collection with some blood products. GI consulted and feel that pancreatitis was likely due to COVID19. Due to the continued deterioration of the patient's condition despite maximal medical effort, patient's brother, with discussion with palliative medicine, decided to pursue comfort care. patient was placed on comfort care 12/14 and expired 17:21. Family was contacted, declines autopsy.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization with Covid-19 after being fully vaccinated.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact unknown.  Not due booster
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Patient called and stated that arm around area where she got her vaccine on 1/21/22 is itchy and red, but it didn't start until 2 days after her shot. She had no issues with the other Moderna shots.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Pyrexia, Respiratory tract congestion
Clinical narrative: fever, congestion, cough, short of breath
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: fever, congestion, cough, short of breath
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fall, Laboratory test, Loss of consciousness
Clinical narrative: He was a very healthy man, slight COPD.  He suddenly felt very dizzy and weak. Fell in the bathroom. Once the ambulance came and they lifted him up he turned gray and passed out completely. Wasn?t out for long, they had thought a stroke. It was not a stroke.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: He was a very healthy man, slight COPD.  He suddenly felt very dizzy and weak. Fell in the bathroom. Once the ambulance came and they lifted him up he turned gray and passed out completely. Wasn?t out for long, they had thought a stroke. It was not a stroke.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: COVID-19 positive through household contact. Booster not due.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hypoaesthesia, Hypoaesthesia oral, Incomplete course of vaccination, Joint swelling
Clinical narrative: 40 minutes after my dose, the left side of my body tingled and went numb. I took shortness of breath for 48 hours. My lips and tongue as well went numb. I took Benadryl and continued the regime until they next day. I saw my doctor and she recommended the max dose of Benadryl. Every four hours. The numbness lasted for four days. On the fourth day I started feeling itchiness and the was a rash in the 1st 24 hours on my left arm. After the 5th day I felt normal my immune response was that I was down for 4 weeks, my glands and my muscle and joints were swollen. My doctor advise that I advised that I do not get the 2nd dose, because the first reaction was a sign that there may be an allergic reaction.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Muscle swelling, Paraesthesia, Pruritus, Rash
Clinical narrative: 40 minutes after my dose, the left side of my body tingled and went numb. I took shortness of breath for 48 hours. My lips and tongue as well went numb. I took Benadryl and continued the regime until they next day. I saw my doctor and she recommended the max dose of Benadryl. Every four hours. The numbness lasted for four days. On the fourth day I started feeling itchiness and the was a rash in the 1st 24 hours on my left arm. After the 5th day I felt normal my immune response was that I was down for 4 weeks, my glands and my muscle and joints were swollen. My doctor advise that I advised that I do not get the 2nd dose, because the first reaction was a sign that there may be an allergic reaction.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Feeling abnormal, Hypocalcaemia, Hypomagnesaemia
Clinical narrative: admitted 11/15 for acute respiratory failure requiring BiPAP 2/2 COVID with superimposed Strep pneumonia. Patient was initially admitted to hospital and discharged on oral Azithromycin, Augmentin and Prednisone. She stated that, however, she started feeling worse the following week and was found by cleaning lady over the weekend sat at 72%, and EMS was called. Patient Tested positive for Covid on 11/15. Admitted to ICU for acute hypoxic respiratory failure requiring NIPPV. Started on Remdesivir (11/15- 11/20), Dexamethasone IV (stop date 11/24). Urine positive for Strep Pneumonia 11/15. Patient was initially started on Zosyn but was subsequently de-escalated to Levaquin 750 mg (stop date 11/25) for community-acquired superimposed bacterial pneumonia. Patient continued to improve and transferred to step down on 11/19. PT/OT evaluated the patient recommended SNF. Plan to continue to wean oxygen as tolerated. She at the time of discharge is requiring BIPAP overnight and her baseline 5L during the day. Her hospital course was complicated by hypocalcemia and hypomagnesemia. Workup for her hypocalcemia demonstrated only a low Vitamin D which was also replaced. She is being discharged on Ca, Mg, and Vit D replacement.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Mechanical ventilation, Pneumonia, Pneumonia bacterial, Pneumonia streptococcal
Clinical narrative: admitted 11/15 for acute respiratory failure requiring BiPAP 2/2 COVID with superimposed Strep pneumonia. Patient was initially admitted to hospital and discharged on oral Azithromycin, Augmentin and Prednisone. She stated that, however, she started feeling worse the following week and was found by cleaning lady over the weekend sat at 72%, and EMS was called. Patient Tested positive for Covid on 11/15. Admitted to ICU for acute hypoxic respiratory failure requiring NIPPV. Started on Remdesivir (11/15- 11/20), Dexamethasone IV (stop date 11/24). Urine positive for Strep Pneumonia 11/15. Patient was initially started on Zosyn but was subsequently de-escalated to Levaquin 750 mg (stop date 11/25) for community-acquired superimposed bacterial pneumonia. Patient continued to improve and transferred to step down on 11/19. PT/OT evaluated the patient recommended SNF. Plan to continue to wean oxygen as tolerated. She at the time of discharge is requiring BIPAP overnight and her baseline 5L during the day. Her hospital course was complicated by hypocalcemia and hypomagnesemia. Workup for her hypocalcemia demonstrated only a low Vitamin D which was also replaced. She is being discharged on Ca, Mg, and Vit D replacement.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Superinfection, Urine analysis abnormal, Vitamin D decreased
Clinical narrative: admitted 11/15 for acute respiratory failure requiring BiPAP 2/2 COVID with superimposed Strep pneumonia. Patient was initially admitted to hospital and discharged on oral Azithromycin, Augmentin and Prednisone. She stated that, however, she started feeling worse the following week and was found by cleaning lady over the weekend sat at 72%, and EMS was called. Patient Tested positive for Covid on 11/15. Admitted to ICU for acute hypoxic respiratory failure requiring NIPPV. Started on Remdesivir (11/15- 11/20), Dexamethasone IV (stop date 11/24). Urine positive for Strep Pneumonia 11/15. Patient was initially started on Zosyn but was subsequently de-escalated to Levaquin 750 mg (stop date 11/25) for community-acquired superimposed bacterial pneumonia. Patient continued to improve and transferred to step down on 11/19. PT/OT evaluated the patient recommended SNF. Plan to continue to wean oxygen as tolerated. She at the time of discharge is requiring BIPAP overnight and her baseline 5L during the day. Her hospital course was complicated by hypocalcemia and hypomagnesemia. Workup for her hypocalcemia demonstrated only a low Vitamin D which was also replaced. She is being discharged on Ca, Mg, and Vit D replacement.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Hallucination, Headache, Hyperventilation, Malaise
Clinical narrative: Vomiting 3 hours after vaccine (about 1pm). Seizure 5 hours after vaccine (about 3pm), stiff on left side of body, smacking mouth & deep breathing. This would start & stop about 4 times. Hallucinating for a while beginning about 5 or 6pm, hot all evening, has had a headache every since the seizure, still has body aches & does not feel well.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain, Seizure, Tardive dyskinesia, Vomiting
Clinical narrative: Vomiting 3 hours after vaccine (about 1pm). Seizure 5 hours after vaccine (about 3pm), stiff on left side of body, smacking mouth & deep breathing. This would start & stop about 4 times. Hallucinating for a while beginning about 5 or 6pm, hot all evening, has had a headache every since the seizure, still has body aches & does not feel well.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pain in extremity, Thrombosis, Ultrasound Doppler
Clinical narrative: Around the middle of December, the 12 or the 16th, I had a pain in my right calf, inside of my right calf.  I waited like a week before I sought medical care because it did not go away.  The doctor sent me for a Doppler on my inside right calf, like an echo and that is when they found the blood clots, the  DVT.  Immediately prescribed Xarelto, a one month pack and you go on 20 mg a day.   Unknown if  I have recovered from the AE, I go back to see the doctor in another 2 weeks, hematologist, to see if I  have any predetermined clots. I don't have any predisposition for clotting.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Pyrexia
Clinical narrative: Fatigue, fever, chills, cough, short of breath.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Fatigue, fever, chills, cough, short of breath.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 9/16/21
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: COVID-19 positive through work contact. Up-to-date on booster.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Exposure during pregnancy, Labour induction, Live birth, SARS-CoV-2 test positive
Clinical narrative: 1/11/22 28 yr/o at 38w5d.  presents for planned induction for chronic hypertension at term. 28-year-old gravida 5 para 4 admitted at 39 - weeks gestation for induction with chronic hypertension.  The patient goes through a 6-hour labor and delivery to deliver spontaneously a 7 pound male infant with Apgars of 8 and 9.  General Appearance:    Alert, cooperative, no distress, appears stated age Head:    Normocephalic, without obvious abnormality, atraumatic Eyes:    PERRL, conjunctiva/corneas clear, EOM's intact, fundi    benign, both eyes Ears:    Normal TM's and external ear canals, both ears Nose:   Nares normal, septum midline, mucosa normal, no drainage    or sinus tenderness
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: 8/18/21 diagnosed positive for COVID; received monoclonal antibody infusion on 8/23/21; seen in ED with increasing SOB and cough; on 5L O2 via NC in ED; pt's condition worsened over next few days and required intubation; condition  deteriorated and pt died in the hospital
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, SARS-CoV-2 test positive
Clinical narrative: 8/18/21 diagnosed positive for COVID; received monoclonal antibody infusion on 8/23/21; seen in ED with increasing SOB and cough; on 5L O2 via NC in ED; pt's condition worsened over next few days and required intubation; condition  deteriorated and pt died in the hospital
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG. PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site irritation, Injection site swelling, Rash
Clinical narrative: rash on left armpit and left leg raised irritated red spot at injection site larger than a silver dollar Treated with Allegra Sunday and Monday -  Is  improving.  Called the pediatrican Tuesday 1/25 who asked that I complete this form
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Pyrexia
Clinical narrative: chills, fever, congestion, cough, short of breath
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: chills, fever, congestion, cough, short of breath
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15 year old inadvertently was administered Moderna 0.50 mL as her first dose.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Vaccine was administered to a 13 y/o child. J & J vaccine is not approved for individuals under age 18 years. Mother was contacted to determine if the child experienced any adverse effects from the vaccine on 1) the day of the clinic, and post vaccine day 1 and 2. Mother denied that the child experienced any adverse effects from the J and J vaccine.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dizziness, Fatigue, Headache
Clinical narrative: I had something like a sinus infection, a sore throat, coughing in chest, congestion, dizziness, and a headache. I felt tired, and I was coughing a lot. I also had a fever.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: I had something like a sinus infection, a sore throat, coughing in chest, congestion, dizziness, and a headache. I felt tired, and I was coughing a lot. I also had a fever.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive through community contact.  Not due for Booster
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nausea, Pyrexia, Respiratory tract congestion
Clinical narrative: cough, congestion, fever, nausea
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: cough, congestion, fever, nausea
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Aspiration, Atrial fibrillation, CHA2DS2-VASc-score
Clinical narrative: Patient is a 73 y old F with T2DM, hypothyroidism, OSA, HTN, HLD, depression, and CKD stage 1-2 who was admitted to HCF 12/10/21 for AHRF 2/2 COVID PNA. Episode of aspiration whilst on NIV which dramatically increased her O2 requirement 12/10 and was subsequently intubated. 12/13 developed episodes of intermittent A fib with normal ventricular rate and was anticoagulated with heparin due to CHA2DS2-VASc score of 4. Started ertapenem 12/14 for UTI and possible aspiration pneumonia coverage. On 12/20, patient's central line was being removed in the afternoon when she went into asystole. A code was called, with ROSC achieved. Passed ZEEP trial on 12/28 on 5/5 support, extubated later that day. Transferred from HCF to FM service, general floor on 1/2, where she continued to wean O2 until on room air. Evaluated by PT/OT, with SNF recommended. Pt and family ultimately elected for Home Health and pt stable for discharge 1/20 with HH services arranged.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiac arrest, Cardio-respiratory arrest, Endotracheal intubation
Clinical narrative: Patient is a 73 y old F with T2DM, hypothyroidism, OSA, HTN, HLD, depression, and CKD stage 1-2 who was admitted to HCF 12/10/21 for AHRF 2/2 COVID PNA. Episode of aspiration whilst on NIV which dramatically increased her O2 requirement 12/10 and was subsequently intubated. 12/13 developed episodes of intermittent A fib with normal ventricular rate and was anticoagulated with heparin due to CHA2DS2-VASc score of 4. Started ertapenem 12/14 for UTI and possible aspiration pneumonia coverage. On 12/20, patient's central line was being removed in the afternoon when she went into asystole. A code was called, with ROSC achieved. Passed ZEEP trial on 12/28 on 5/5 support, extubated later that day. Transferred from HCF to FM service, general floor on 1/2, where she continued to wean O2 until on room air. Evaluated by PT/OT, with SNF recommended. Pt and family ultimately elected for Home Health and pt stable for discharge 1/20 with HH services arranged.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient is a 73 y old F with T2DM, hypothyroidism, OSA, HTN, HLD, depression, and CKD stage 1-2 who was admitted to HCF 12/10/21 for AHRF 2/2 COVID PNA. Episode of aspiration whilst on NIV which dramatically increased her O2 requirement 12/10 and was subsequently intubated. 12/13 developed episodes of intermittent A fib with normal ventricular rate and was anticoagulated with heparin due to CHA2DS2-VASc score of 4. Started ertapenem 12/14 for UTI and possible aspiration pneumonia coverage. On 12/20, patient's central line was being removed in the afternoon when she went into asystole. A code was called, with ROSC achieved. Passed ZEEP trial on 12/28 on 5/5 support, extubated later that day. Transferred from HCF to FM service, general floor on 1/2, where she continued to wean O2 until on room air. Evaluated by PT/OT, with SNF recommended. Pt and family ultimately elected for Home Health and pt stable for discharge 1/20 with HH services arranged.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Breast cancer male, Condition aggravated, Lymphadenopathy
Clinical narrative: Patient now has breast cancer and lymph nodes increased in size 3 months after 3rd pfizer in September
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Cholecystitis, Cholelithiasis, Computerised tomogram abdomen abnormal, Diarrhoea, Endoscopic retrograde cholangiopancreatography abnormal
Clinical narrative: Severe cramping, diarrhea and bleeding, Gall stone, nausea, vomited bile, fever, pending gall bladder removal.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Haemorrhage, Magnetic resonance cholangiopancreatography, Muscle spasms, Nausea, Pyrexia
Clinical narrative: Severe cramping, diarrhea and bleeding, Gall stone, nausea, vomited bile, fever, pending gall bladder removal.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Severe cramping, diarrhea and bleeding, Gall stone, nausea, vomited bile, fever, pending gall bladder removal.
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Urticaria
Clinical narrative: Hives on neck and chest.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: PATIENT WAS ADMINISTERED PEDIATRIC DOSE INSTEAD OF DOSE FOR 12 AND OLDER. NO ADVERSE EFFECTS OCCURRED. CDC WAS CONTACTED FOR ADVISEMENT. ADVICE GIVEN WAS NOT TO GIVE AN ADDITIONAL DOSE. INFORMATION IS TO BE PASSED TO THE MINOR'S GUARDIAN
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: rash and redness over half of my body for a week
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Lot FL0007 09/2021 diluted on 1/24/22 at 0954, labeled to expire on 1/24/22 at 2154 stored in vaccine fridge overnight after clinic closed and into today.  A vaccine was administered today at approximately 1205.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT HAS BEEN ADVISED AND MAY GET REVACCINATED.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Paraesthesia, Polymenorrhoea, Pruritus, Urticaria
Clinical narrative: Hives; itchy, prickly, hot sensation (all over body) and shorted menstrual cycle.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Lethargy, Screaming
Clinical narrative: pt was directed to sit outside for 15 minutes after vaccines  after covid Pfizer was administered . RPH heard parent screaming in waiting area and saw pt lethargic and in parent arms , kind of limp. rph called 911 and asked pharmacy staff to call 911 while staying on the phone with 911 operator . rph asked pt how she is feeling and she said ok but she was covered in profuse sweat . took winter jacket off upon removing jacket pt seemed better . the EMT arrived and took pt outside of waiting area . tried to contact parents as follow up but had no response
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysstasia, Fall, Gait inability
Clinical narrative: Fiorst shot, fell; second shot, unable to stand or walk
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, COVID-19, Chronic kidney disease, Condition aggravated
Clinical narrative: Hospital Course: Came in for (+) COVID-19 and hypoxia. Started on dexamethasone. Remdesivir was held due to AKI on CKD. Home O2 was passed on 12/21 but needed to watch patient overnight to ensure adequate renal function and urine output. Metabolic panel this morning was significantly improved. Will RX Robitussin PRN to assist with secretions/cough. Of note, patient had a (+) DVT in Right upper extremity. Will continue same Therapeutic Lovenox dose (80 mg BID) and repeat US in 1 week. She does have a follow up appt with Dr. in the local clinic on January 4, 2022. Will discharge with 2 additional days of dexamethasone and follow up with PCP in 1 week. Patient has home O2 and a spO2. She will continue to monitor her O2 status and was instructed to call her PCP or UH for an additional 5 days of dexamethasone (10 days total) if her spO2 is <90%.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Deep vein thrombosis, Hypoxia, Metabolic function test abnormal, Renal function test
Clinical narrative: Hospital Course: Came in for (+) COVID-19 and hypoxia. Started on dexamethasone. Remdesivir was held due to AKI on CKD. Home O2 was passed on 12/21 but needed to watch patient overnight to ensure adequate renal function and urine output. Metabolic panel this morning was significantly improved. Will RX Robitussin PRN to assist with secretions/cough. Of note, patient had a (+) DVT in Right upper extremity. Will continue same Therapeutic Lovenox dose (80 mg BID) and repeat US in 1 week. She does have a follow up appt with Dr. in the local clinic on January 4, 2022. Will discharge with 2 additional days of dexamethasone and follow up with PCP in 1 week. Patient has home O2 and a spO2. She will continue to monitor her O2 status and was instructed to call her PCP or UH for an additional 5 days of dexamethasone (10 days total) if her spO2 is <90%.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Secretion discharge, Ultrasound Doppler abnormal, Urine output
Clinical narrative: Hospital Course: Came in for (+) COVID-19 and hypoxia. Started on dexamethasone. Remdesivir was held due to AKI on CKD. Home O2 was passed on 12/21 but needed to watch patient overnight to ensure adequate renal function and urine output. Metabolic panel this morning was significantly improved. Will RX Robitussin PRN to assist with secretions/cough. Of note, patient had a (+) DVT in Right upper extremity. Will continue same Therapeutic Lovenox dose (80 mg BID) and repeat US in 1 week. She does have a follow up appt with Dr. in the local clinic on January 4, 2022. Will discharge with 2 additional days of dexamethasone and follow up with PCP in 1 week. Patient has home O2 and a spO2. She will continue to monitor her O2 status and was instructed to call her PCP or UH for an additional 5 days of dexamethasone (10 days total) if her spO2 is <90%.